Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom May Launch Gene-Expression Service This Year; Genotyping Service to Follow

SALT LAKE CITY, Oct. 31 (GenomeWeb News) - After launching its DNA-methylation-analysis service last week, Sequenom will likely launch a gene-expression service within the year, and launch a genotyping service later, company officials told GenomeWeb News last week.


Sequenom is currently taking the first orders for its expression service, so "one could argue that it's being launched now," said Christian Jurinke, the company's director of product development. He spoke with GenomeWeb News during the American Society for Human Genetics meeting, held here last week.


The expression service will likely officially launch before the end of the year, with a genotyping service launch to follow soon after, said Jurinke. He declined to provide a more specific timeline.


The two new services have the potential to complement the company's new DNA-methylation service, but they will not be explicitly linked in any way in the near future, said Jurinke.


As GenomeWeb News reported, Sequenom launched its methylation detection service last Wednesday. The company provided preview versions of its upcoming DNA-methylation-detection software product for the MassArray platform to four investigators, Jurinke said.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.